QuidelOrtho Partners With BYG4lab® to Strengthen Informatics Offerings
24 Juli 2023 - 9:00PM
Business Wire
Strategic partnership will add middleware
and data management solutions across the company’s diagnostics
portfolio
QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or
“QuidelOrtho”), a global provider of innovative in vitro
diagnostics technologies designed for point-of-care settings,
clinical labs and transfusion medicine, announced today that it has
entered into a software development partnership with BYG4lab®, a
leading provider of middleware and data management solutions for
laboratories, that intends to accelerate QuidelOrtho’s efforts to
expand and strengthen informatics offerings across its portfolio of
diagnostics platforms.
“Our partnership with BYG4lab® reaches across the business, from
clinical labs to transfusion medicine to point-of-care, and it
allows QuidelOrtho to rapidly integrate affordable, cutting-edge
and time-saving informatics solutions,” said Douglas Bryant,
President and Chief Executive Officer of QuidelOrtho. “Building
this powerful data management capability into our portfolio
offering will be yet another proof point in our commitment to
engineering user-friendly innovations that enable customers to
standardize and automate manual processes to boost efficiencies at
single sites and across networks.”
QuidelOrtho’s partnership with BYG4lab®, a proven company that
understands the data management challenges labs face, expands on an
existing agreement between both companies pertaining to France and
is a strategic catalyst that will accelerate the development of
innovative solutions that can be used across the entire lab. The
companies will work jointly to address the immediate workflow and
labor challenges within the global laboratory community through
proprietary tools that allow auto-verification to become more
routine and available to labs of all sizes. This partnership
reflects QuidelOrtho’s appreciation of the importance of
informatics to today’s labs and the Company’s determination to
create robust solutions that are agile and can be updated quickly
and easily to support our customers’ needs.
“With ever-increasing testing demands and decreasing staffing
availability, accurate and automated record collection and
management are critical to assuring the highest quality of patient
care,” Mr. Bryant noted. “QuidelOrtho is committed to provide
integrated diagnostics systems and informatics solutions that
bridge the gap and give our customers an edge.”
About QuidelOrtho Corporation
QuidelOrtho Corporation (Nasdaq: QDEL) is a world leader in in
vitro diagnostics, developing and manufacturing intelligent
solutions that transform data into understanding and action for
more people in more places every day.
Offering industry-leading expertise in immunoassay and molecular
testing, clinical chemistry and transfusion medicine, bringing
fast, accurate and reliable diagnostics when and where they are
needed – from home to hospital, lab to clinic. So that patients,
clinicians and health officials can spot trends sooner, respond
quicker and chart the course ahead with accuracy and
confidence.
Building upon its 80-year legacy of groundbreaking innovation,
QuidelOrtho continues to partner with customers across the
healthcare continuum and around the globe to forge a new diagnostic
frontier. One where insights and solutions know no bounds,
expertise seamlessly connects and a more informed path is
illuminated for each of us.
QuidelOrtho is transforming the power of diagnostics into a
healthier future for all.
For more information, please visit www.quidelortho.com.
Source: QuidelOrtho Corporation
About BYG4lab®
BYG INFORMATIQUE is a software company specialized in Middleware
Data Management solutions covering all disciplines in the
healthcare industry. More than 4000 laboratories worldwide are
using BYG4lab® data management solutions on a daily basis through
E.O.M dedicated workstations. In addition, more than 500
laboratories are using BYG4lab® Off-the-shelf solutions through its
legacy portfolio: the universal connector B-Link™, EVM™ (Central
lab) or Pilot NextGen® (Microbiology), or through the brand new
Yline® technical baseline and innovative web-based architecture
which includes nYna® (Central Lab), pocY® (POCT), and Ynfectio®
(Epidemiology). The company provides innovative multi-language
solutions driving efficiency and cost effectiveness by: improving
workflow management; making instrument integration more efficient;
handling multi-sites and multi-LIS configurations; ensuring
regulatory and legal compliances (ISO 15189); providing an
innovative Method validation module; including full QC package; and
giving tangible dynamics’ indicators for improving and controlling
workflow. BYG INFORMATIQUE is the privileged partner of several
companies in the IVD industry through its complete Middleware suite
or through specific full Data Management solutions or specific
modules. BYG4lab®’s solutions are distributed worldwide and
available in 11 languages. BYG INFORMATIQUE is ISO 13485: 2016
certified and follows the most demanding international
recommendations regarding the medical software development cycle
(CEN 62304) , cybersecurity and data Privacy.
For more information, please visit www.byg4lab.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230724368435/en/
BYG4lab® Media: Alexandre Rousseaux – Business Developer
Management – alexandre.rousseaux@byg4lab.com
QuidelOrtho Media: media@QuidelOrtho.com
QuidelOrtho (NASDAQ:QDEL)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
QuidelOrtho (NASDAQ:QDEL)
Historical Stock Chart
Von Mai 2023 bis Mai 2024